Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


21.01.2019

1 Acta Oncol
1 Afr J Reprod Health
1 Anal Chem
1 Anat Cell Biol
1 Anticancer Res
1 Biomed Res Int
3 BMC Cancer
1 BMC Infect Dis
1 Bull Cancer
1 Cancer Chemother Pharmacol
1 Cancer Res
1 Gene
1 Gynecol Oncol
1 Health Qual Life Outcomes
2 Int J Cancer
9 Int J Gynecol Cancer
1 Int J Mol Sci
2 J Cell Physiol
1 J Epidemiol Community Health
1 J Obstet Gynaecol Res
1 J Radiat Res
3 JAMA Netw Open
2 Lancet
1 Nat Commun
1 Oxid Med Cell Longev
1 Radiat Oncol
1 Radiat Oncol J
1 Surg Oncol
1 Surg Res Pract
1 Taiwan J Obstet Gynecol
1 Tex Med
1 Womens Health Issues


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Oncol

  1. GANGOPADHYAY A
    Neutrophil lymphocyte ratio is significantly associated with complete response to chemoradiation in locally advanced cervical cancer.
    Acta Oncol. 2019 Jan 11:1-3. doi: 10.1080/0284186X.2018.1556803.
    PubMed     Text format    


    Afr J Reprod Health

  2. NYAMBE N, Hoover S, Pinder LF, Chibwesha CJ, et al
    Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia.
    Afr J Reprod Health. 2018;22:92-101.
    PubMed     Text format     Abstract available


    Anal Chem

  3. REN W, Mohammed SI, Wereley ST, Irudayaraj J, et al
    Magnetic focus lateral flow sensor for detection of cervical cancer biomarkers.
    Anal Chem. 2019 Jan 11. doi: 10.1021/acs.analchem.8b04848.
    PubMed     Text format     Abstract available


    Anat Cell Biol

  4. ALI A, Kim MJ, Kim MY, Lee HJ, et al
    Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase.
    Anat Cell Biol. 2018;51:274-283.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. DE LIMA TM, DE Azevedo Focchi GR, DE Almeida BC, Belfort-Mattos PN, et al
    Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.
    Anticancer Res. 2018;38:6673-6681.
    PubMed     Text format     Abstract available


    Biomed Res Int

  6. MONJARAS-AVILA C, Bernal-Silva S, Bach H
    Development of Novel Single-Chain Antibodies against the Hydrophobic HPV-16 E5 Protein.
    Biomed Res Int. 2018;2018:5809028.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. TEMPFER CB, Tischoff I, Dogan A, Hilal Z, et al
    Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    BMC Cancer. 2018;18:530.
    PubMed     Text format     Abstract available

  8. ITTIAMORNLERT P, Ruengkhachorn I
    Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy.
    BMC Cancer. 2019;19:51.
    PubMed     Text format     Abstract available

  9. SUZUKI Y, Tokinaga-Uchiyama A, Mizushima T, Maruyama Y, et al
    Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.
    BMC Cancer. 2018;18:973.
    PubMed     Text format     Abstract available


    BMC Infect Dis

  10. TORRES-POVEDA K, Bahena-Roman M, Delgado-Romero K, Madrid-Marina V, et al
    A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
    BMC Infect Dis. 2018;18:582.
    PubMed     Text format     Abstract available


    Bull Cancer

  11. WORONOFF AS, Molinie F, Tretarre B
    [Implementation of National Cervical Cancer Screening Program in France].
    Bull Cancer. 2019 Jan 8. pii: S0007-4551(18)30370.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  12. JIA QP, Yan CY, Zheng XR, Pan X, et al
    Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-kappaB/APOBEC3B cascade.
    Cancer Chemother Pharmacol. 2019 Jan 10. pii: 10.1007/s00280-018-03766.
    PubMed     Text format     Abstract available


    Cancer Res

  13. YAGI A, Ueda Y, Kakuda M, Tanaka Y, et al
    Epidemiological and clinical analyses of cervical cancer using data from the population-based Osaka cancer registry.
    Cancer Res. 2019 Jan 11. pii: 0008-5472.CAN-18-3109.
    PubMed     Text format     Abstract available


    Gene

  14. GUO Q, Xiong Y, Song Y, Hua K, et al
    ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30024-1. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  15. KIM SI, Cho JH, Seol A, Kim YI, et al
    Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Gynecol Oncol. 2019 Jan 11. pii: S0090-8258(19)30041.
    PubMed     Text format     Abstract available


    Health Qual Life Outcomes

  16. ARAYA LT, Gebretekle GB, Gebremariam GT, Fenta TG, et al
    Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Health Qual Life Outcomes. 2019;17:13.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. BAUSSANO I, Lazzarato F, Ronco G, Franceschi S, et al
    Impacts of human papillomavirus vaccination for different populations: A modeling study.
    Int J Cancer. 2018;143:1086-1092.
    PubMed     Text format     Abstract available

  18. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  19. HATA M
    Radiation therapy for elderly patients with uterine cervical cancer: feasibility of curative treatment.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000077.
    PubMed     Text format     Abstract available

  20. HOREWEG N, Creutzberg CL, Rijkmans EC, Laman MS, et al
    Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000057.
    PubMed     Text format     Abstract available

  21. CIBULA D, Dusek J, Jarkovsky J, Dundr P, et al
    A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
    Int J Gynecol Cancer. 2019;29:212-215.
    PubMed     Text format     Abstract available

  22. CHONG GO, Han HS, Park JY, Lee SD, et al
    Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
    Int J Gynecol Cancer. 2019;29:10-16.
    PubMed     Text format     Abstract available

  23. YAVAS G, Yavas C, Sen E, Oner I, et al
    Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019;29:42-47.
    PubMed     Text format     Abstract available

  24. YOSHINO Y, Taguchi A, Shimizuguchi T, Nakajima Y, et al
    A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy.
    Int J Gynecol Cancer. 2019;29:17-22.
    PubMed     Text format     Abstract available

  25. NEWMAN H, Hu J, Li X, He J, et al
    Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
    Int J Gynecol Cancer. 2019;29:23-27.
    PubMed     Text format     Abstract available

  26. CORDERO-GALLARDO F, Lee Burnett O 3rd, McNamara MM, Weber TM, et al
    Incidence of mesorectal node metastasis in locally advanced cervical cancer: its therapeutic implications.
    Int J Gynecol Cancer. 2019;29:48-52.
    PubMed     Text format     Abstract available

  27. RAJASOORIYAR C, Lin MY, Kalra R, Lim A, et al
    The role of positron emission tomography in the selection of patients for salvage hysterectomy following chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Jan 10. pii: ijgc-2018-000088.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  28. XU L, Padalko E, Ostrbenk A, Poljak M, et al
    Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Cell Physiol

  29. SONG T, Xu A, Zhang Z, Gao F, et al
    CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075.
    J Cell Physiol. 2019 Jan 11. doi: 10.1002/jcp.28128.
    PubMed     Text format     Abstract available

  30. HAN X, Wang Q, Wang Y, Hu B, et al
    Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
    J Cell Physiol. 2019 Jan 11. doi: 10.1002/jcp.28113.
    PubMed     Text format     Abstract available


    J Epidemiol Community Health

  31. SMITH-GAGEN J, White LL, Santos A, Hasty SM, et al
    Scope-of-practice laws and expanded health services: the case of underserved women and advanced cervical cancer diagnoses.
    J Epidemiol Community Health. 2019 Jan 11. pii: jech-2018-210709.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  32. GUO JL, Han T, Bao L, Li XM, et al
    Ursolic acid promotes the apoptosis of cervical cancer cells by regulating endoplasmic reticulum stress.
    J Obstet Gynaecol Res. 2019 Jan 10. doi: 10.1111/jog.13919.
    PubMed     Text format     Abstract available


    J Radiat Res

  33. KAWASHIMA A, Isohashi F, Mabuchi S, Sawada K, et al
    A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.
    J Radiat Res. 2019 Jan 11. pii: 5288300. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA Netw Open

  34. KOUYOUMDJIAN FG, McConnon A, Herrington ERS, Fung K, et al
    Cervical Cancer Screening Access for Women Who Experience Imprisonment in Ontario, Canada.
    JAMA Netw Open. 2018;1:e185637.
    PubMed     Text format     Abstract available

  35. ELIT LM, Fyles AW, Gu CS, Pond GR, et al
    Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
    JAMA Netw Open. 2018;1:e182081.
    PubMed     Text format     Abstract available

  36. HELMAN SR, Stevanovic S, Campbell TE, Kwong MLM, et al
    Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design.
    JAMA Netw Open. 2018;1:e180706.
    PubMed     Text format     Abstract available


    Lancet

  37. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed     Text format    

  38. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Text format     Abstract available


    Nat Commun

  39. LI Z, Song S, He M, Wang D, et al
    Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity.
    Nat Commun. 2018;9:5360.
    PubMed     Text format     Abstract available


    Oxid Med Cell Longev

  40. YUAN YG, Zhang S, Hwang JY, Kong IK, et al
    Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells.
    Oxid Med Cell Longev. 2018;2018:6121328.
    PubMed     Text format     Abstract available


    Radiat Oncol

  41. HU K, Wang W, Liu X, Meng Q, et al
    Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Radiat Oncol. 2018;13:249.
    PubMed     Text format     Abstract available


    Radiat Oncol J

  42. CHO O, Chun M
    Management for locally advanced cervical cancer: new trends and controversial issues.
    Radiat Oncol J. 2018;36:254-264.
    PubMed     Text format     Abstract available


    Surg Oncol

  43. YIN S, Ma SN, Zhang YQ, Shi TY, et al
    Surgical and oncological outcomes of an improved nerve-sparing radical hysterectomy technique: 6 years of experience at two centres.
    Surg Oncol. 2018;27:380-386.
    PubMed     Text format     Abstract available


    Surg Res Pract

  44. NUCHPRAMOOL P, Hanprasertpong J
    Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer.
    Surg Res Pract. 2018;2018:9162921.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  45. HUANG WC, Hsiao YC, Wu CC, Hsu YT, et al
    Less circulating mucosal-associated invariant T cells in patients with cervical cancer.
    Taiwan J Obstet Gynecol. 2019;58:117-121.
    PubMed     Text format     Abstract available


    Tex Med

  46. WILEY R, Shelal Z, Urbauer D, Bernard C, et al
    Relationship Between Intent to Vaccinate and the Education and Knowledge of Human Papillomavirus Among Medical School Faculty and Students in Texas.
    Tex Med. 2019;115:e1.
    PubMed     Text format     Abstract available


    Womens Health Issues

  47. CHARLTON BM, Kahn JA, Sarda V, Katz-Wise SL, et al
    Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention.
    Womens Health Issues. 2019 Jan 10. pii: S1049-3867(18)30414.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: